Founded and led a $50M seed financing for K2 Therapeutics, a Singapore-based biotech spun out of MPM BioImpact.
K2 Therapeutics is a biotech company built for global impact, with search and development capabilities unconstrained by modality or geography
K2 Therapeutics is a biotech company built for global impact, with search and development capabilities unconstrained by modality or geography. We identify the world’s most innovative assets and translate them into great medicines through a disciplined development approach and lead by experienced drug developers. Our focus is on high-potential first- and best-in-class assets with meaningful potential for patient impact worldwide.